Engineering Venom’s Toxin-Neutralizing Antibody Fragments and Its Therapeutic Potential
Clicks: 267
ID: 273331
2014
Serum therapy remains the only specific treatment against envenoming, but anti-venoms are still prepared by fragmentation of polyclonal antibodies isolated from hyper-immunized horse serum. Most of these anti-venoms are considered to be efficient, but their production is tedious, and their use may be associated with adverse effects. Recombinant antibodies and smaller functional units are now emerging as credible alternatives and constitute a source of still unexploited biomolecules capable of neutralizing venoms. This review will be a walk through the technologies that have recently been applied leading to novel antibody formats with better properties in terms of homogeneity, specific activity and possible safety.
| Reference Key |
alvarenga2014toxinsengineering
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Larissa M. Alvarenga;Muhammad Zahid;Anne Di Tommaso;Matthieu O. Juste;Nicolas Aubrey;Philippe Billiald;Julien Muzard;Alvarenga, Larissa M.;Zahid, Muhammad;Tommaso, Anne Di;Juste, Matthieu O.;Aubrey, Nicolas;Billiald, Philippe;Muzard, Julien; |
| Journal | Toxins |
| Year | 2014 |
| DOI | 10.3390/toxins6082541 |
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.